Print Preview Area

Limb-girdle myasthenia with tubular aggregates associated with novel GFPT1 mutations
Muscle & Nerve, 05/10/2012

Huh SY et al. – Glutamine–fructose–6–phosphate transaminase 1 (GFPT1) is the key enzyme in the hexosamine biosynthesis pathway, and mutations in GFPT1 cause defective glycosylation in the proteins of the neuromuscular junction. Identification of Limb–girdle myasthenia with tubular aggregates (LGM with TAs) among patients with congenital myasthenic syndrome is important, because treatment with cholinesterase inhibitors can produce symptomatic improvement. This is the first reported case of LGM with TA associated with GFPT1 mutations in the Asian population.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Physician Assistant Jobs
@MDLinx Career Center
View the full listing of physician jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Limb-girdle myasthenia with tubular aggregates associated with novel GFPT1 mutations Muscle & Nerve, 05/10/2012

Limb-girdle myasthenia with tubular aggregates associated with novel GFPT1 mutations
Muscle & Nerve, 05/10/2012